Skip to main content
News

BioTalk Podcast Welcomes Immunyx Pharma Co-Founder & CEO, Seth Salpeter

By March 13, 2023No Comments
Seth and Rich Gif

Seth and Rich Gif

Want to be on the cutting edge of disease treatment? Learn how companies like Immunyx Pharma are changing the landscape of immune modulation in the battle against diseases with the JLABS/BARDA Blue Knight program on this episode of BioTalk with Rich Bendis.

Also Available on popular podcast platforms like Apple https://apple.co/3LlbxIy, Google https://bit.ly/3l6O6ba, Spotify https://spoti.fi/405ln5B, Amazon Music https://amzn.to/3J58kde, TuneIn https://bit.ly/3JA8MBO, and even YouTube https://bit.ly/3LhYZS6.

Dr. Seth Salpeter has deep experience in developing and bringing new biotechnologies to market. Currently he serves as Co-Founder and CEO of Immunyx Pharma, a biotech focused on developing immuno-modulatory therapies for chronic diseases and as Co-Founder and CTO at Curesponse, a precision cancer medicine company. Prior to that he was Chief Scientist and VP Business Development at Sight Diagnostics. Dr. Salpeter holds a Ph.D in Biochemistry from the Hebrew University and performed post-doctoral studies at the Institute for Drug Research, the Hebrew University School of Pharmacy.

Click here to read the transcript.

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.